Research Article
Diagnosis of Oral Hairy Leukoplakia: The Importance of EBV In Situ Hybridization
Table 1
Comparison between presence of oral hairy leukoplakia and quantitative variables of the patients.
| | Variable | Oral hairy leukoplakia | | Mean | SD | Median | | |
| | Age (years) | Yes | 20 | 41.9 | 6.8 | 42.5 | 505 | 0.030 | | No | 74 | 46.1 | 10.7 | 47.0 | | Time of infection (years) | Yes | 20 | 11.2 | 5.5 | 11.0 | 613 | 0.239 | | No | 74 | 12.8 | 4.9 | 13.0 | | Lowest CD4 count (cells/mm3) | Yes | 20 | 197.4 | 200.8 | 150.0 | 648.5 | 0.446 | | No | 73 | 212.4 | 168.4 | 200.0 | | Current CD4 count (cells/mm3) | Yes | 20 | 504.7 | 243.1 | 507.0 | 692.5 | 0.726 | | No | 73 | 544.5 | 301.4 | 500.0 | | HIV-viral load (log copies/ml) | Yes | 20 | 1.1 | 1.9 | 0.0 | 625 | 0.155 | | No | 73 | 0.6 | 1.4 | 0.0 | | Duration of ARVT (years) | Yes | 20 | 8.8 | 5.0 | 8.5 | 606 | 0.360 | | No | 70 | 9.6 | 4.6 | 10.0 | | Current duration of ARVT (years) | Yes | 20 | 2.9 | 2.7 | 2.0 | 554 | 0.154 | | No | 70 | 4.1 | 3.6 | 3.5 |
|
|
Mann–Whitney test. SD: standard deviation; ARVT: antiretroviral therapy.
|
